All In MedTech

Device Trial Radar · NCT01713062

Longterm-Evaluation of Vitelene® Against Standard

Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

400

Actual

Start

Jan 2012

Primary completion

Apr 2027

Study completion Jun 2030

Sponsor

Lead sponsor
Aesculap AGNot on our public-company list
Sponsor type
Industry
First posted
Oct 24, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this randomised prospective multicenter longterm study is to evaluate the survival rate of the implant, wear and periprosthetic osteolysis of highly cross-linked polyethylene with and without addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X) in Total Hip Arthroplasty.

Conditions

  • Osteoarthritis, Hip
  • Arthritis

Interventions

  • ViteleneDevice

    THA

  • XLPEDevice

    THA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Analysis and measurement of oxidation index of the Polyethylene Inlay after RevisionTime frame: Oxidation index is assessed in case of loosening and revision within 15 years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Fachklinik für Orthopädie, Unfallchirurgie, WirbelsäulenchirurgieMarienhaus Klinikum St. Josef

    Bendorf, Germany

  • Klinik für Orthopädie und Unfallchirurgie

    Bochum, Germany

  • Klinik und Poliklinik für Orthopädie

    Halle, Germany

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.